Neurogenetic Diseases Treatment Platform: ASO-Based Treatments
Neurogenetic Diseases Treatment Platform: ASO-Based Treatments ASO-Based Treatments Antisense oligonucleotides (ASOs) are short, synthetic, …
Read ArticleWe want to share good news with you.
The design of the genetic drug we developed for Rett and Dravet Syndrome has been completed in the current status of the drug study.
Our design successfully passed the tests for body temperature and binding pattern preservation in computer environment.
We will have the first syntheses of our drug at the beginning of the year. We are starting production.
#RettSyndrome #DravetSyndrome #GeneticDrug #DrugDevelopment #ComputerSimulation #MolecularDesign #SynthesisProcess #Neurogenetics #RareDisease #GeneticTreatment #Pharmacology #Neurology #GeneticSyndrome #DrugResearch #MolecularModeling